10 Participants Needed

Deep Brain Stimulation for Cerebral Palsy

MS
SW
Overseen BySarah Wang, PhD, CCRP
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I need to stop my current medications for the trial?

The trial does not specify if you need to stop taking your current medications. However, it mentions that participants should have a history of trying oral medications without adequate relief, so it's possible you may need to continue them.

What data supports the effectiveness of the treatment Cerebellar Deep Brain Stimulation for Cerebral Palsy?

Research shows that Cerebellar Deep Brain Stimulation (DBS) can help improve movement issues in people with cerebral palsy, such as reducing muscle stiffness and involuntary movements. Studies have reported improvements in spasticity, speech, and overall functional status, with continued benefits over time.12345

Is deep brain stimulation safe for treating cerebral palsy and other conditions?

Deep brain stimulation (DBS) has been used in various conditions, including cerebral palsy and cerebellar ataxia, and is generally considered safe. Studies have shown it to be well tolerated without serious adverse events, although one patient required electrode repositioning.23678

How is Cerebellar Deep Brain Stimulation different from other treatments for cerebral palsy?

Cerebellar Deep Brain Stimulation (DBS) is unique because it involves placing electrodes in the cerebellum (a part of the brain that helps control movement) to reduce symptoms like spasticity and improve motor function. Unlike medications, which can be unsatisfactory, this treatment directly targets brain areas to help manage movement disorders in cerebral palsy.12689

What is the purpose of this trial?

The purpose of this study is to test the safety of placing Deep Brain Stimulators (DBS) in a part of the brain called the cerebellum and using electrical stimulation of that part of the brain to treat movement symptoms related to cerebral palsy. Ten children and young adults with dyskinetic cerebral palsy will be implanted with a Medtronic Percept Primary Cell Neurostimulator. We will pilot videotaped automated movement recognition techniques and formal gait analysis, as well as collect and characterize each subject's physiological and neuroimaging markers that may predict hyperkinetic pathological states and their response to therapeutic DBS.

Research Team

MS

Marta San Luciano Palenzuela

Principal Investigator

University of California, San Francisco

Eligibility Criteria

This trial is for children and young adults aged 7-25 with dyskinetic cerebral palsy (DCP), who have tried oral medications without enough relief. They should be able to attend follow-up visits, have a history of brain injury before their motor symptoms started, and not have major cerebellar abnormalities on an MRI.

Inclusion Criteria

No gross cerebellar abnormalities observed and reported on structural MRI
My family and I have chosen surgery with DBS for my movement disorder.
My mobility is moderately to severely limited.
See 13 more

Exclusion Criteria

Pregnancy: all women of child-bearing potential will be required to have a negative urine pregnancy test prior to undergoing their surgical procedure
I have severe joint stiffness or bone deformities that would not show improvement.
I need treatments like diathermy, electroconvulsive therapy, or magnetic stimulation.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Open-label Phase

Participants undergo an open label phase to titrate stimulation and determine optimal stimulation settings

20 weeks

Randomized Blinded Phase

Participants start three cycles of randomized, paired 8-week exposure periods, each pair including effective stimulation followed by sham stimulation, or vice versa

24 weeks
Weekly evaluations

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Cerebellar Deep Brain Stimulation
Trial Overview The study tests the safety of Deep Brain Stimulation (DBS) in the cerebellum using Medtronic Percept Neurostimulators to treat movement disorders caused by cerebral palsy. It includes videotaped movement analysis, gait analysis, and monitoring physiological and neuroimaging markers.
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: Effective stimulationActive Control1 Intervention
All participants will receive deep brain stimulation (DBS) in the cerebellum. For the first 20 weeks, every participant undergoes an open label phase to titrate stimulation and determine optimal stimulation settings. Following that phase, each participant starts three cycles of randomized, paired 8-week exposure periods, each pair including effective stimulation followed by sham stimulation, or vice versa. Effective stimulation will be the optimal stimulation settings determined during the open label phase.
Group II: Sham stimulationPlacebo Group1 Intervention
Sham stimulation will be settings at low amplitude (0.1mA) known to be ineffective.

Cerebellar Deep Brain Stimulation is already approved in United States for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as Cerebellar Deep Brain Stimulation for:
  • Dyskinetic cerebral palsy
  • Movement disorders in cerebral palsy

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Trials
1,403
Recruited
655,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Findings from Research

Deep cerebellar stimulation significantly reduced muscle tone and improved psychomotor status in 11 out of 13 patients with cerebral palsy over a 2-year follow-up, with notable improvements in walking and speech for some individuals.
The procedure is considered safe and effective, being non-ablative and reversible, although there were some complications, including infections in 23.1% of cases, which led to the removal of stimulators in two patients.
Clinical evaluation of deep cerebellar stimulation for spasticity in patients with cerebral palsy.Harat, M., Radziszewski, K., Rudaล›, M., et al.[2016]
Dyskinetic cerebral palsy (DCP) presents significant treatment challenges due to its complex motor symptoms, including chorea, athetosis, and dystonia, which are often not effectively managed with pharmacological options.
Deep brain stimulation (DBS) targeting the basal ganglia or cerebellum shows promise as a therapeutic approach for selected patients with DCP, based on a review of the largest available studies on this treatment.
Deep brain stimulation for dystonia due to cerebral palsy: A review.Elia, AE., Bagella, CF., Ferrรฉ, F., et al.[2018]
Bilateral deep brain stimulation (DBS) targeting the dentate nucleus in three patients with dyskinetic cerebral palsy (DCP) was found to be safe and resulted in subjective and objective improvements in motor function, as measured by the Burke-Fahn-Marsden Dystonia Rating Scale.
The study suggests that the cerebellum may be a promising target for DBS in DCP patients, as it is often spared from hypoxic ischemic damage, but further research with larger sample sizes and long-term follow-up is needed to confirm these preliminary findings.
Cerebellar deep brain stimulation for the treatment of movement disorders in cerebral palsy.Cajigas, I., Morrison, MA., Luciano, MS., et al.[2023]

References

Clinical evaluation of deep cerebellar stimulation for spasticity in patients with cerebral palsy. [2016]
Deep brain stimulation for dystonia due to cerebral palsy: A review. [2018]
Cerebellar deep brain stimulation for the treatment of movement disorders in cerebral palsy. [2023]
Chronic cerebellar stimulation in cerebral palsy. [2019]
[The influence of permanent cerebellar stimulation on senso-motor disorders in cerebral palsy (author's transl)]. [2006]
Long-Term Follow-Up of Pediatric Patients with Dyskinetic Cerebral Palsy and Deep Brain Stimulation. [2023]
Safety and Outcomes of Dentate Nucleus Deep Brain Stimulation for Cerebellar Ataxia. [2022]
Behavioural responses to cerebellar stimulation in cerebral palsy. [2019]
Motor and psychological responses to deep cerebellar stimulation in cerebral palsy (correlation with organization of cerebellum into zones). [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity